— Know what they know.
Not Investment Advice

RGLS NASDAQ

Regulus Therapeutics Inc.
1W: -0.6% 1M: +3.2% 3M: +532.6% 1Y: +298.1% 3Y: +191.4% 5Y: -2.9%
$8.16
Last traded 2025-06-26 — delisted
NASDAQ · Healthcare · Biotechnology · $565.0M mcap · 57M float · 4.32% daily turnover · Short 33% of daily vol

No ESG data available for RGLS

ESG scores are derived from SEC filings (10-K, 10-Q) and may not be available for all companies.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms